Preventing microvascular complications in type 1 diabetes mellitus

Article English OPEN
Viswanathan, Vijay (2015)
  • Publisher: Medknow Publications & Media Pvt Ltd
  • Journal: Indian Journal of Endocrinology and Metabolism, volume 19, issue Suppl 1, pages S36-S38 (issn: 2230-8210, eissn: 2230-9500)
  • Related identifiers: doi: 10.4103/2230-8210.155382, pmc: PMC4413386
  • Subject: Diseases of the digestive system. Gastroenterology | type 1 diabetes mellitus | retinopathy | RC648-665 | RC799-869 | Nephropathy | neuropathy | Brief Communication | Diseases of the endocrine glands. Clinical endocrinology

Patients with complications of diabetes such as retinopathy, nephropathy, and cardiovascular complications have increased hospital stay with greater economic burden. Prevention of complications should be started before the onset of type 1 diabetes mellitus (T1DM) by working on risk factors and thereafter by intervention upon confirmatory diagnosis which can prevent further damage to β-cells. The actual risk of getting microvascular complications like microalbuminuria and retinopathy progression starts at glycated hemoglobin (HbA1c) level of 7%. As per the American Diabetes Association, a new pediatric glycemic control target of HbA1c <7.5% across all ages replaces previous guidelines that had called for different targets by age. Evidence shows that prevalence of microvascular complications is greater in patients with age >20 years as compared to patients <10 years of age. Screening of these complications should be done regularly, and appropriate preventive strategies should be followed. Angiotensin converting enzyme inhibitors and angiotensin II receptor blocker reduce progression from microalbuminuria to macroalbuminuria and increase the regression rate to normoalbuminuria. Diabetic microvascular complications can be controlled with tight glycemic therapy, dyslipidemia management and blood pressure control along with renal function monitoring, lifestyle changes, including smoking cessation and low-protein diet. An integrated and personalized care would reduce the risk of development of microvascular complications in T1DM patients. The child with diabetes who receives limited care is more likely to develop long-term complications at an earlier age. Screening for subclinical complications and early interventions with intensive therapy is the need of the hour.
Share - Bookmark